Global Top 13 Companies Accounted for 31% of total Sustained-release Medicine market (QYResearch, 20 (Business Opportunities - Other Business Ads)

UKAdsList > Business Opportunities > Other Business Ads

Item ID 9504545 in Category: Business Opportunities - Other Business Ads

Global Top 13 Companies Accounted for 31% of total Sustained-release Medicine market (QYResearch, 20


Sustained-release Medicine refer to preparations that can be continuously released for a long time after administration to achieve long-acting effects, and the drug release is mainly a first-order rate process. Controlled release preparations (controlled release preparations) refer to the preparations that can automatically release the drug at a predetermined speed within a predetermined time, so that the blood drug concentration can be kept constant within the effective concentration range for a long time.
Since there is no difference between sustained-release preparations and controlled-release preparations in the some countries, so, in this report, Extended release (ER), Sustained release (SR), Controlled release (CR) and Delayed release (DR), are assumed to be the same.
The global key manufacturers of Sustained-release Medicine include Sanofi, Novartis, AbbVie, AstraZeneca, Takeda, Johnson & Johnson, Bayer, Pfizer, Shanghai Shyndec Pharmaceutical, Collegium Pharmaceutical, Inc, etc.
In 2022, the global top five players had a share approximately 31.0% in terms of revenue.

For more information, please contact the following e-mail address:
Email: global@qyresearch.com
Website: https://www.qyresearch.com



Target Nation: All Nations
Target City : All Cities
Last Update : 16 April 2024 7:41 AM
Number of Views: 17
Item  Owner  : Emily
Contact Email: (None)
Contact Phone: (None)

Friendly reminder: Click here to read some tips.
UKAdsList > Business Opportunities > Other Business Ads
 © 2024 UKAdsList.com
2024-05-03 (0.254 sec)